The effect of ivabradine on long term prevention of major adverse cardiac events in acute coronary syndrome using high-sensitivity C-reactive protein level
Introduction: C-reactive protein (CRP) value can identify the risk level for acute coronary syndrome (ACS). Ivabradine, a selective inhibitor of the funny current channel, reduces resting and exercise HR without affecting cardiac contractility or blood pressure. Aim of work: Evaluate the influence o...
Main Authors: | Ahmed Fouad AbdEl Latif, Wael Samy, Mohamed Y. Khaled, Alia Abd El Fattah |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2015-08-01
|
Series: | Egyptian Journal of Critical Care Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090730315000298 |
Similar Items
-
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01) -
IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01) -
Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01) -
IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER
by: E. I. Tarlovskaya
Published: (2018-04-01) -
Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)